# Role of Preoperative Tapentadol in Reduction of Perioperative Analgesic Requirement After Breast Conservative Surgery in Cancer Patients.

> **NCT07320781** · NA · COMPLETED · sponsor: **Shaukat Khanum Memorial Cancer Hospital & Research Centre** · enrollment: 70 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Tapentadol
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07320781
- **Lead sponsor:** Shaukat Khanum Memorial Cancer Hospital & Research Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-15
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-10-10
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07320781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07320781, "Role of Preoperative Tapentadol in Reduction of Perioperative Analgesic Requirement After Breast Conservative Surgery in Cancer Patients.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07320781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*